Day: June 24, 2020

WISeKey Appoints Philippe Gerwill to its Advisory CommitteeGeneva – June 24, 2020 – WISeKey International Holding Ltd (“WISeKey”, SIX: WIHN / NASDAQ: WKEY), a leading cybersecurity and IoT company, today announced the appointment  of Philippe Gerwill to its Advisory Committee. Members of WISeKey’s Advisory Committee originate from a wide variety of sectors that are of critical importance to WISeKey’s growth strategy, including Cybersecurity, IoT, Blockchain, and information technology.

Orphazyme A/SCompany announcement                                                                                      No. 36/2020                                                                                                          Company Registration No. 32266355 Arimoclomol demonstrated a marked and clinically meaningful dose-dependent reduction in liver and spleen sizePrimary endpoint demonstrating relative reduction in chitotriosidase levels from baseline was observed, although did not achieve statistical significanceData supports Orphazyme’s intention to proceed with pivotal stage clinical development in Gaucher diseaseCopenhagen, Denmark, June 24, 2020 – Orphazyme A/S (ORPHA.CO), a late-stage biopharmaceutical company pioneering the Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases, today announces...

Innate Pharma to re-activate TELLOMAK trial in the USNew GMP-certified batch has been successfully manufacturedConference call to be held today on the lacutamab clinical trial program Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has lifted the partial clinical hold placed on the lacutamab TELLOMAK Phase II clinical trial, evaluating the efficacy and safety of lacutamab (formerly IPH4102) in patients with advanced T-cell lymphomas. The FDA decision is based on a quality assessment of a new Good Manufacturing Practice (GMP)-certified batch that has been successfully manufactured for the lacutamab clinical development program, including the TELLOMAK trial. The Company can now resume recruitment of new patients in the...

Réactivation de l’essai TELLOMAK aux Etats-UnisUn nouveau lot de produit clinique certifié Bonnes Pratiques de Fabrication a été fabriqué avec succèsUne conférence téléphonique qui fera le point sur le programme d’essai clinique de lacutamab aura lieu aujourd’huiInnate Pharma SA (Euronext Paris : IPH – ISIN : FR0010331421 ; Nasdaq : IPHA) (« Innate » ou la « Société ») a annoncé aujourd’hui que l’agence américaine du médicament (FDA, Food and Drug Administration) a levé la suspension partielle de l’essai clinique de Phase II TELLOMAK, évaluant l’efficacité et la tolérance de lacutamab (auparavant IPH4102) chez les patients présentant un lymphome T avancé. La décision de la FDA s’appuie sur l’évaluation d’un nouveau lot de produit clinique certifié Bonnes Pratiques de Fabrication (BPF) fabriqué avec succès pour le programme clinique évaluant...

Paris, June 24, 2020 – Today, at the occasion of a fully global and digital 2020 Analyst Day, the Group presents its Vision, Ambition and Strategy in the mid-term.Elie Girard, CEO said: “Atos’ ambition is to become the leader in secure and decarbonized digital. Over the next years, the Group will pivot towards growth, leveraging on SPRING to move Atos to an Industry approach and capture this decade’s new Cloud and Digital breakthroughs, on Digital Security to increase further its leadership, and on Decarbonization where Atos is a pioneer in bringing to its customers its unique know-how both on core IT, and on business processes. Acquisitions of bolt-on Digital specialists as well as Cybersecurity experts will enhance Atos offering and growth profile.As a result of this strategy, Digital, Cloud, Security, and Decarbonization are expected...

Paris, le 24 juin 2020 – Aujourd’hui, à l’occasion de sa Journée Analystes 2020 entièrement globale et numérique, le Groupe présente sa Vision, son Ambition et sa Stratégie à moyen terme.Elie Girard, Directeur Général, a déclaré : « L’ambition d’Atos est de devenir le leader du Numérique Sécurisé et Décarboné. Pour les années qui viennent, le Groupe se tourne avant tout vers la croissance, en s’appuyant sur son programme SPRING, afin d’adopter une approche Sectorielle et saisir les nouvelles avancées du Cloud et du Digital de cette décennie; dans le Numérique Sécurisé pour renforcer davantage son leadership; sur la Décarbonation où Atos est un pionnier en fournissant à ses clients un savoir-faire unique à la fois informatique et dans les processus métiers. Les acquisitions ciblées de sociétés spécialisées dans le numérique ou expertes...

VANCOUVER, British Columbia, June 23, 2020 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) announced today that it has priced an offering of senior unsecured notes.Teck will issue US$550 million principal amount of 10-year senior unsecured notes, which will bear interest at the rate of 3.900% per annum.The offering is expected to close on or about June 30, 2020, subject to customary closing conditions. The net proceeds from the offering of the notes are expected to be approximately US$542.2 million after the initial purchasers’ fees and estimated offering expenses.Teck intends to use the net proceeds from the offering, together with cash on hand if necessary, to fund its previously announced tender offers to purchase any and all of the combined US$538,695,000 aggregate principal amount outstanding...

EBÈNE, Mauritius, June 23, 2020 (GLOBE NEWSWIRE) — Ceridian (NYSE: CDAY; TSX: CDAY), a global leader in human capital management (HCM), today announced the availability of its award-winning Dayforce platform in the Mauritius market. Ceridian is also pleased to announce that IBL Group, the country’s largest conglomerate, selected Dayforce to modernize its HR and people processes as part of an enterprise-wide culture change to become more client-centric.“The launch of Dayforce will enable companies with operations in Mauritius to leverage modern technology to make smarter business decisions, and create experiences employees love,” said David Ossip, Chairman and CEO, Ceridian. “The decision by IBL Group, one of the biggest employers in Mauritius, to choose Dayforce, reflects the continued confidence global companies have in our...

CAMBRIDGE, Mass., June 23, 2020 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced the pricing of an underwritten offering of 6,000,000 shares of its common stock at a public offering price of $31.25 per share, before deducting underwriter discounts and commissions and estimated offering expenses. Gross proceeds from the offering are expected to be approximately $187.5 million. Editas Medicine has granted the underwriter a 30-day option to purchase up to an additional 900,000 shares of common stock on the same terms and conditions. All of the shares in the offering are to be sold by Editas Medicine. The offering is expected to close on or about June 26, 2020, subject to customary closing conditions.Morgan Stanley is acting as sole book-running manager for the offering.A registration...

MONTREAL, June 23, 2020 (GLOBE NEWSWIRE) — IPL Plastics Inc. (“IPL Plastics”, “IPLP”, the “Group” or the “Company”) (TSX: IPLP) announces today the voting results for the election of directors. The election was held earlier today in Montreal, during the Annual and Special Meeting of Shareholders of the Company.All of the candidates proposed by management in the Company’s Management Information Circular were elected as directors by the shareholders present or represented by proxy at the meeting.The detailed results of the vote are as follows:Voting results on all matters voted on at the Annual and Special Meeting of the Company will be published on IPL’s website, www.iplglobal.com, and filed with the Canadian securities regulators.About IPLPIPLP is a leading sustainable packaging solutions provider primarily in the food, consumer,...